Caplin Point bets big on US, complex injectables to drive next growth phase: COO

Caplin Point is building a strong growth runway with over 40 US approvals, a 60-plus product pipeline and aggressive capacity expansion, says COO Vivek Partheeban. While growth may moderate in the near term, the US business, larger Latin American markets and complex products could drive a sharper pickup from FY28 onwards.